Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideEWEdwards Lifesciences
FinDog View：Neutral
JNJJohnson & Johnson
FinDog View：Bullish
| Metric | EW | JNJ |
|---|
| Close | 92.01 | 273.20 |
| Market Cap | $53.6B | $666B |
| 1M | +6.59% | +3.20% |
| P/E (TTM) | 53.7 | 41.3 |
| Forward P/E | 31.0 | 22.0 |
| P/E 5-Yr Percentile | 100 | 100 |
| P/S | 8.3 | 6.7 |
| P/B | 5.1 | 7.8 |
| Dividend Yield | — | 3.12% |
| Latest Quarter Revenue | $1.7B | $25.4B |
| Revenue YoY | +13.6% | +5.9% |
| Gross Margin | 77.5% | 68.1% |
| Latest Quarter EPS | 0.42 | 0.09 |
| Avg Post-Earnings Move | ±3.9% | ±0.6% |
| EPS Beat Rate | — | 1 / 1 |
| Guidance Hit Rate | 2 / 2 | — |
| Shareholder Yield | 2.25% | 1.18% |
| 90-Day Net Insider Buying | −$3.5M | −$62.0M |
EW · Revenue, Last 8 Quarters ($B)
JNJ · Revenue, Last 8 Quarters ($B)
